Psoriasis drug safety checked in kids over years
Disease control
Ongoing
This study tracks the long-term safety of the drug ustekinumab in children aged 6 to 17 with moderate to severe plaque psoriasis. Researchers monitor for serious infections, cancers, and autoimmune problems, as well as effects on growth and puberty. About 135 kids are being obser…
Sponsor: Janssen-Cilag International NV • Aim: Disease control
Last updated May 06, 2026 16:13 UTC